Thomas Jefferson University

Main menu:

Recent Publications

Recent Publications

Efficacy of DSP30-IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner

Increasing resident utilization and recognition of the critical view of safety during laparoscopic cholecystectomy: a pilot study from an academic medical center

Endovascular Repair of Ruptured Infected Arteries as a Temporizing Measure Versus Destination Therapy

Association of inflammation prior to kidney transplantation with post-transplant diabetes mellitus

Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors

Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity

Liver retransplantation for recurrence of HCV-related cirrhosis using hepatitis C-positive allografts: A 19-year OPTN analysis

Median arcuate ligament syndrome - Review of this rare disease

The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells

Insights from HuR biology point to potential improvement for second-line ovarian cancer therapy

EBV-associated Peripheral T-Cell Lymphoma of Gastrointestinal Tract Presented With Widespread Chronic Inflammation: A Case Report

Dcc Mediates Functional Assembly of Peripheral Auditory Circuits

Delivery of Therapeutics Targeting the mRNA Binding Protein HuR Using 3DNA Nanocarriers Suppresses Ovarian Tumor Growth

Autologous human plasma in stem cell culture and cryopreservation in the creation of a tissue-engineered vascular graft

Living scaffolds: surgical repair using scaffolds seeded with human adipose-derived stem cells

The landscape of pancreatic cancer therapeutic resistance mechanisms

Personalized therapy for Pancreatic Cancer: Do we need better targets, arrows, or both?

Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine

HuR contributes to TRAIL resistance by restricting death receptor 4 expression in pancreatic cancer cells